Combined impact of body mass index and glycemic control on the efficacy of clopidogrel-aspirin therapy in patients with minor stroke or transient ischemic attack | Zendy

Zimo Chen | Zendy; Jinglin Mo | Zendy; Jie Xu | Zendy; Anxin Wang | Zendy; Haiqiang Qin | Zendy; Huaguang Zheng | Zendy; Liping Liu | Zendy; Xia Meng | Zendy; Hao Li | Zendy; Yongjun Wang | Zendy

Open Access

Combined impact of body mass index and glycemic control on the efficacy of clopidogrel-aspirin therapy in patients with minor stroke or transient ischemic attack

Author(s) -

Zimo Chen,

Jinglin Mo,

Jie Xu,

Anxin Wang,

Haiqiang Qin,

Huaguang Zheng,

Liping Liu,

Xia Meng,

Hao Li,

Yongjun Wang

Publication year - 2020

Publication title -

aging

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.473

H-Index - 90

ISSN - 1945-4589

DOI - 10.18632/aging.103394

Subject(s) - medicine , clopidogrel , aspirin , overweight , body mass index , hazard ratio , glycemic , stroke (engine) , cardiology , confidence interval , insulin , mechanical engineering , engineering

A single index of body mass index (BMI) may not fully address its impact on anti-platelet therapy. We aimed to elucidate the combined impact of BMI and dysglycemia expressed by glycated albumin (GA) on efficacy of clopidogrel-aspirin therapy among minor stroke (MS) or transient ischemic attack (TIA) patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research